Ελληνική Αλλεργιολογία & Κλινική Ανοσολογία - ΒΗΤΑ Ιατρικές ...

88 Κ. Πεταλάς και συν52. Davis RS, Remigio LK, Schoket AL et al. Evaluation of a patientwith both aquagenic and cholinergic urticaria. J Allergy ClinImmunol 1981, 68:479–48353. Chalamidas SL, Charles CR. Aquagenic urticaria. Arch Dermatol1971, 104:541–54654. Parker RK, Crowe MJ, Guin JD. Aquagenic urticaria. Cutis 1992,50:283–28455. Mathelier-Fusade P, Aissaoui M, Chabane MH et al. Association ofcold urticaria and aquagenic urticaria. Allergy 1997, 52:678–67956. Sibbald RG, Kobza Black A, Eady RAJ et al. Aquagenic urticaria:evidence of cholinergic and histaminergic basis. Br J Dermatol1981, 105:297–30257. Czarnetzki BM, Breetholt KH, Traupe H. Evidence that water actsas a carrier for an epidermal antigen in aquagenic urticaria. J AmAcad Dermatol 1986, 15:623–62758. Tkach JR. Aquagenic urticaria. Cutis 1981, 28, 454, 46359. Martinez-Escribano JA, Quecedo E, de la Cuadra J et al. Treatmentof aquagenic urticaria with PUVA and astemizole. J Am AcadDermatol 1997, 36:118–11960. Juhlin L, Malmros-Enander I. Familial polymorphous light eruptionwith aquagenic urticaria: successful treatment with PUVA.Photodermatol 1986, 3:346–34961. Fearfield LA, Gazzard B, Bunker CB. Aquagenic urticaria andhuman immunodeficiency virus infection: treatment with stanozolol.Br J Dermatol 1997, 137:620–62262. Patterson R, Mellies CJ, Blankenship ML et al. Vibratory angioedema:a hereditary type of physical hypersensitivity. J Allergy ClinImmunol 1972, 50:174–18263. Metzger WJ, Kaplan AP, Beaven MA et al. Hereditary vibratoryangioedema: confirmation of histamine release in a type of physicalhypersensitivity. J Allergy Clin Immunol 1976, 57:605–60864. Rose M. Vibratory urticaria associated with bladder-wall infectionwith the yeast Torulopsis glabrata. J Allergy Clin Immunol1989, 84:40865. Ting S, Reimann BEF, Rauls DO, Mansfield LE. Nonfamilial,vibration-induced angioedema. J Allergy Clin Immunol 1983,71:546–55166. Hoffman HM, Wanderer AA, Broide DH. Familial cold autoinflammatorysyndrome: phenotype and genotype of an autosomaldominant periodic fever. J Allergy Clin Immunol 2001,108:61567. Drenth JPH, van Der Meer JWM. Hereditary periodic fever. NEngl J Med 2001, 345:1748–175768. Neittaanmaki H. Cold urticaria: clinical findings in 220 patients.J Am Acad Dermatol 1985, 13:636–64469. Ting S. Cold-induced urticaria in infancy. Pediatrics 1984, 73:105–10670. Wanderer AA, Grandel KE, Wasserman SI et al. Clinical characteristicsof cold-induced systemic reactions in acquired cold urticariasyndromes: recommendations for prevention of this complicationand a proposal for a diagnostic classification of cold urticaria. JAllergy Clin Immunol 1986, 78:416–42371. Kaplan AP, Garofalo J, Sigler R et al. Idiopathic cold urticaria: invitro demonstration of histamine release upon challenge of skinbiopsies. N Engl J Med 1981, 305:1074–107772. Mathews KP. Exploiting the cold-urticaria model. N Engl J Med1981, 305:1090–109273. Gruber BL, Baeza ML, Marchese MJ et al. Autoantibodies in urticarialsyndromes. J Invest Dermatol 1988, 90:213–21774. Kaplan AP, Garofalo J. Identification of a new physically inducedurticaria: cold induced cholinergic urticaria. J Allergy ClinImmunol 1981, 68:438–44175. Dubertret L, Pecquet C, Murrieta-Aguttes M et al. Mizolastinein primary acquired cold urticaria. J Am Acad Dermatol 2003,48:578–58376. Bonadonna P, Lombardi C, Senna G et al. Treatment of severe coldurticaria with associated cetirizine and zafirlukast. J Allergy ClinImmunol 2003, 111:S23677. Kaplan AP, Horakova Z, Katz SI. Assessment of tissue fluid histaminelevels in patients with urticaria. J Allergy Clin Immunol1978, 68:43878. Czarnetzski BM, Meentken J, Rosenbach T. Clinical, pharmacologicaland immunological aspects of delayed pressure urticaria.Br J Dermatol 1984, 111:31579. Lawlor F, Barr R, Kobza Black A et al. Arachidonic acid transformationis not stimulated in delayed pressure urticaria. Br JDermatol 1989, 121:31780. Lawlor F, Bird C, Camp R et al. Increased interleukin-6 but reducedinterleukin-1 in delayed pressure urticaria. Br J Dermatol 1993,128–50081. Leiferman KM, Haugen HS, Gleich GJ. Evidence for eosinophildegranulation in the late phase of the immediate weal and flareskin reaction. J Invest Dermatol 1986, 56:48882. Lawlor F, Kobza Black A, Milford Ward A et al. Delayed pressureurticaria, objective evaluation of a variable disease using a dermographometer:an assessment of therapy using colchicine. Br JDermatol 1989, 120:40583. Barlow RJ, Warburton F, Watson K et al. The diagnosis and evidenceof delayed pressure urticaria in patients with chronic urticaria.J Am Acad Dermatol 1993, 29:954–95884. Barlow RJ, Ross EL, Macdonald D et al. Adhesion molecule expressionand the inflammatory cell infiltrate in delayed pressure urticaria.Br J Dermatol 1994, 131:341–34785. Finlay AY, Khan GK. Dermatology life quality index (DCQ1) asimple practical measure for routine clinical use. Brit J Dermatol1994, 19:21086. Kontou-Fili K, Maniatakou G, Demaka P et al. Therapeutic effectsof cetirizine 2HCI in delayed pressure urticaria: clinicopathologicfindings. J Am Acad Dermatol 1991, 24:109087. Kobza Black A. Delayed pressure urticaria. J Invest Dermatol 2001,6:148